Pfizer Global Medical Grants (GMG) – Digital Education to Address Patients with COVID-19 and High Risk of Complications RFP
Academic Unit: inquire with unit
Memorial Deadline: Friday 5th, August 2022
External Deadline: Wednesday 10th, August 2022
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Application Due Date: August 10, 2022
Specific Area of Interest: Through this RFP it is our intent to support digital/online educational programs for primary care clinicians designed to increase the understanding of:
- – The need for early diagnosis and intervention for patients with COVID-19 and a high risk of complications
- – Treatment of acute COVID-19 in a primary care setting
- Refer to complete details in the full RFP documents. If you have questions regarding this RFP, please direct them in writing to Derek Warnick, Grant Officer (firstname.lastname@example.org).